Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05296473. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Randomized, Controlled, Parallel-group, Intervention Study to Assess an At-home, Game-based Digital Therapy for Treating Adult Patients With Attention-Deficit/Hyperactivity Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).
Study identification
- NCT ID
- NCT05296473
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 560 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 5, 2022 (Actual)
- Primary completion
- Mar 12, 2024 (Actual)
- Completion
- Mar 12, 2024 (Actual)
- Last update posted
- Sep 19, 2024
2022 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melmed Center | Scottsdale | Arizona | 85254 | — |
| CNS Network | Garden Grove | California | 92845 | — |
| University of California Davis MIND Institute | Sacramento | California | 95817 | — |
| University of California San Francisco | San Francisco | California | 94143 | — |
| Accel Research Sites - Maitland Clinical Research Unit | Maitland | Florida | 32751 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Alivation Research, LLC | Lincoln | Nebraska | 68526 | — |
| Center of Psychiatry and Behavioral Medicine | Las Vegas | Nevada | 89128 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Mindpath Care Centers | Raleigh | North Carolina | 27606 | — |
| CNS Healthcare | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials of Dallas | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05296473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2024 · Synced Nov 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.